Todd Mcdevitt, PhD

Senior Investigator, Gladstone Institute
Department of Bioengineering and Therapeutic Sciences
+1 415 734-2875

Dr. McDevitt is a Senior Investigator at the Gladstone Institute of Cardiovascular Disease and a Professor of Bioengineering and Therapeutics at the University of California, San Francisco. He was previously the founding Director of the Stem Cell Engineering Center at Georgia Tech, the Carol Ann and David D. Flanagan Professor in the Wallace H. Coulter Department of Biomedical Engineering, and a Petit Faculty Fellow in the Parker H. Petit Institute for Bioengineering and Bioscience. Dr. McDevitt has 18 years of experience in biomaterials and tissue engineering research and for the past 14 years has focused primarily on stem cell biology and engineering. One of the primary objectives of Dr. McDevitt’s research is to engineer tissues, largely from stem cell sources, for regenerative medicine and in vitro diagnostic applications. Much of the research in the McDevitt laboratory focuses on the application of microtechnologies to engineer 3D environments in order to more effectively control multicellular organization that better recapitulates complex tissue structure and subsequent function.


Enhanced in vivo retention of low dose BMP-2 via heparin microparticle delivery does not accelerate bone healing in a critically sized femoral defect.

Acta biomaterialia

Hettiaratchi MH, Rouse T, Chou C, Krishnan L, Stevens HY, Li MA, McDevitt TC, Guldberg RE

Competitive Protein Binding Influences Heparin-Based Modulation of Spatial Growth Factor Delivery for Bone Regeneration.

Tissue engineering. Part A

Hettiaratchi MH, Chou C, Servies N, Smeekens JM, Cheng A, Esancy C, Wu R, McDevitt TC, Guldberg RE, Krishnan L